Literature DB >> 30127919

Identification of six serum antigens and autoantibodies for the detection of early stage epithelial ovarian carcinoma by bioinformatics analysis and liquid chip analysis.

Yupeng Zou1, Li Li1.   

Abstract

The early detection of ovarian cancer is critical for improving the prognosis of patients, but there are currently insufficient tumor biomarkers for early detection owing to their low diagnostic sensitivity and specificity. The aim of the present study was to investigate the use of the serum antigens C-C motif chemokine ligand 18 and C-X-C motif chemokine ligand 1, and autoantibodies C1D, transmembrane 4 L six family member 1, zinc finger protein 675 and fragile X mental retardation 1 autosomal homolog 1, for the early screening of epithelial ovarian cancer (EOC). The expression of these sex genes/proteins in ovarian cancer and normal ovarian tissue was examined, and the potential functions of the six genes/proteins in ovarian cancer were analyzed by bioinformatics. Finally, these data were verified in clinical samples, and the multi-analyte suspension array method was compared with the ELISA method. Taken together, these data indicated that these six genes/proteins may serve as potential biomarkers for the early detection of EOC.

Entities:  

Keywords:  biomarker; early diagnosis; liquid chip; multi-index joint detection; ovarian cancer

Year:  2018        PMID: 30127919      PMCID: PMC6096275          DOI: 10.3892/ol.2018.9027

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  28 in total

1.  Identification of biologically active chemokine isoforms from ascitic fluid and elevated levels of CCL18/pulmonary and activation-regulated chemokine in ovarian carcinoma.

Authors:  Evemie Schutyser; Sofie Struyf; Paul Proost; Ghislain Opdenakker; Genevieve Laureys; Bruno Verhasselt; Lieven Peperstraete; Ignace Van de Putte; Alessandra Saccani; Paola Allavena; Alberto Mantovani; Jo Van Damme
Journal:  J Biol Chem       Date:  2002-04-26       Impact factor: 5.157

2.  FXR1: Linking cellular quiescence, immune genes and cancer.

Authors:  Radhika Raheja; Roopali Gandhi
Journal:  Cell Cycle       Date:  2016-07-26       Impact factor: 4.534

Review 3.  Ovarian cancer recurrence and early detection: may HE4 play a key role in this open challenge? A systematic review of literature.

Authors:  Stella Capriglione; Daniela Luvero; Francesco Plotti; Corrado Terranova; Roberto Montera; Giuseppe Scaletta; Teresa Schirò; Gianmarco Rossini; Pierluigi Benedetti Panici; Roberto Angioli
Journal:  Med Oncol       Date:  2017-08-20       Impact factor: 3.064

4.  Cancer Statistics, 2017.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2017-01-05       Impact factor: 508.702

Review 5.  Why have ovarian cancer mortality rates declined? Part II. Case-fatality.

Authors:  Victoria Sopik; Javaid Iqbal; Barry Rosen; Steven A Narod
Journal:  Gynecol Oncol       Date:  2015-06-14       Impact factor: 5.482

6.  [Identification of two potential serum biomarkers for ovarian cancer and clinical validation thereof].

Authors:  Qi Wang; Wei Zhang; Dan-rong Li; Li Li
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2008-04-15

7.  The RNA binding protein FXR1 is a new driver in the 3q26-29 amplicon and predicts poor prognosis in human cancers.

Authors:  Jun Qian; Mohamed Hassanein; Megan D Hoeksema; Bradford K Harris; Yong Zou; Heidi Chen; Pengcheng Lu; Rosana Eisenberg; Jing Wang; Allan Espinosa; Xiangming Ji; Fredrick T Harris; S M Jamshedur Rahman; Pierre P Massion
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-02       Impact factor: 11.205

8.  C-X-C motif chemokine 12/C-X-C chemokine receptor type 7 signaling regulates breast cancer growth and metastasis by modulating the tumor microenvironment.

Authors:  Nissar Wani; Mohd W Nasser; Dinesh K Ahirwar; Helong Zhao; Zhenhua Miao; Konstantin Shilo; Ramesh K Ganju
Journal:  Breast Cancer Res       Date:  2014-05-29       Impact factor: 6.466

9.  CCL18 from tumor-cells promotes epithelial ovarian cancer metastasis via mTOR signaling pathway.

Authors:  Qi Wang; Yong Tang; Hongjing Yu; Qiaoyun Yin; Mengdi Li; Lijun Shi; Wei Zhang; Danrong Li; Li Li
Journal:  Mol Carcinog       Date:  2015-10-12       Impact factor: 4.784

10.  Performance of seven criteria to assess CA125 increments among ovarian cancer patients monitored during first-line chemotherapy and the post-therapy follow-up period.

Authors:  Suher O Abu Hassan; Dorte L Nielsen; Malgorzata K Tuxen; Per H Petersen; György Sölétormos
Journal:  Future Sci OA       Date:  2017-07-18
View more
  1 in total

1.  A combined biomarker panel shows improved sensitivity and specificity for detection of ovarian cancer.

Authors:  Lu Mao; Yong Tang; Ming-Jing Deng; Chun-Tao Huang; Dong Lan; Wen-Zheng Nong; Li Li; Qi Wang
Journal:  J Clin Lab Anal       Date:  2022-01-07       Impact factor: 2.352

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.